Compounding pharmacies SUE the FDA for restricting off-label Tirzepatide production and favoring Eli Lilly
| (NaturalNews) Eli Lilly, a large pharmaceutical company, is facing a new legal battle that will determine whether Big Pharma and the FDA can stifle out competition... |